PMS of Trazenta on the Long-term Use as Add-on Therapy

Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea

NCT02090673 ·Status: COMPLETED

Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus

NCT00935532 ·Status: COMPLETED ·Phase: PHASE3

GALLANT 8 Tesaglitazar Add-on to Metformin

NCT00251953 ·Status: TERMINATED ·Phase: PHASE3

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

NCT05433584 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

NCT00658021 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus

NCT03131687 ·Status: COMPLETED ·Phase: PHASE2

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

NCT06297603 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

NCT00790153 ·Status: COMPLETED ·Phase: PHASE1

Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus

NCT02392117 ·Status: COMPLETED

A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

NCT00823940 ·Status: COMPLETED ·Phase: PHASE1

Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents

NCT00099333 ·Status: COMPLETED ·Phase: PHASE2

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

NCT00280865 ·Status: COMPLETED ·Phase: PHASE2

GALLANT 4 Tesaglitazar vs. Glibenclamide

NCT00255541 ·Status: TERMINATED ·Phase: PHASE3

Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes Mellitus

NCT01451398 ·Status: COMPLETED ·Phase: PHASE3

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

NCT01654120 ·Status: COMPLETED ·Phase: PHASE4

Linagliptin as Add on to Basal Insulin in the Elderly

NCT02240680 ·Status: COMPLETED ·Phase: PHASE4

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan

NCT06635057 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT06132126 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

NCT05260021 ·Status: COMPLETED ·Phase: PHASE3

Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes

NCT00511602 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

NCT01620489 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

NCT01554618 ·Status: COMPLETED ·Phase: PHASE3

Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)

NCT00308139 ·Status: COMPLETED ·Phase: PHASE3

Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes

NCT01774968 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Exenatide as Monotherapy

NCT00381342 ·Status: COMPLETED ·Phase: PHASE3